Alzheimer's Disease Trial, Recruiting NCT07680335 Sponsor: Alzheimercentrum Amsterdam Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07680335
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have visited a memory clinic because of concerns about their memory or thinking.
  • A doctor suspects that Alzheimer's disease may be the underlying cause of their memory or thinking concerns.
  • People who have a good enough understanding of Dutch to take part in the informed consent process.

Who may not be able to join:

  • People under the age of 55.
  • People who have already been diagnosed with Alzheimer's disease confirmed through biological testing (such as brain scans or spinal fluid tests).
  • People whose alcohol or drug use is considered serious enough that treatment for it would be recommended.
  • People who are not able to understand or judge the consequences of taking part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 020 - 4440816

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Alzheimercentrum Amsterdam
Registry
ClinicalTrials.gov
Start date
17 September 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Time from baseline to final diagnosis; Change in diagnosis; Change in physician's confidence in diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov